Chylomicronemia Syndrome clinical trials at UCSF

1 research study open to eligible people

Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants
open to eligible people ages 2-17
The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.
San Francisco, California and other locations

Last updated: July 28, 2026